Company News

Company News Pharmaceutical Biotechnology Medical Device CRO Contract Outsourcing

Impact of Donald Trump’s Tariffs on Life Science

Since Donald Trump has started his second term in office, it has been a turbulent 100+ days....

By Barrington James May 9th, 2025

Displaying 1 - 4 of 18

Company News Pharmaceutical
The Rise and Growth of Antibody-Drug Conjugates in Cancer Treatment.
Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...

By Barrington James June 18th, 2025
Company News
£86 Billion UK Science & Tech Investment: What It Means for Life Science
The UK’s record £86 billion R&D pledge (worth £22.5 billion a year by FY 2029/30) will f...

By Barrington James June 9th, 2025
Company News
APAC Life Science Executive Search | Nicholas Sim
As APAC Managing Partner at Board & Executive Partners (a Barrington James com...

By Nicholas Sim May 28th, 2025
Company News
Regeneron’s $256M 23andMe Buy: 15M Genomes & R&D Benefits
Regeneron Pharmaceuticals has agreed to acquire almost all of 23andMe’s business lines, whic...

By Barrington James May 20th, 2025